IL152931A0 - BENZOPHENONES AS INHIBITORS OF IL-1beta AND TNF-alpha - Google Patents

BENZOPHENONES AS INHIBITORS OF IL-1beta AND TNF-alpha

Info

Publication number
IL152931A0
IL152931A0 IL15293101A IL15293101A IL152931A0 IL 152931 A0 IL152931 A0 IL 152931A0 IL 15293101 A IL15293101 A IL 15293101A IL 15293101 A IL15293101 A IL 15293101A IL 152931 A0 IL152931 A0 IL 152931A0
Authority
IL
Israel
Prior art keywords
1beta
benzophenones
tnf
inhibitors
alpha
Prior art date
Application number
IL15293101A
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Priority claimed from PCT/DK2001/000346 external-priority patent/WO2001090074A2/en
Publication of IL152931A0 publication Critical patent/IL152931A0/en

Links

IL15293101A 2000-05-22 2001-05-18 BENZOPHENONES AS INHIBITORS OF IL-1beta AND TNF-alpha IL152931A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2057900P 2000-05-22 2000-05-22
PCT/DK2001/000346 WO2001090074A2 (en) 2000-05-22 2001-05-18 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)

Publications (1)

Publication Number Publication Date
IL152931A0 true IL152931A0 (en) 2003-06-24

Family

ID=30113606

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15293101A IL152931A0 (en) 2000-05-22 2001-05-18 BENZOPHENONES AS INHIBITORS OF IL-1beta AND TNF-alpha

Country Status (1)

Country Link
IL (1) IL152931A0 (en)

Similar Documents

Publication Publication Date Title
AU6008101A (en) Benzophenones as inhibitors of il-1beta and tnf-alpha
AU6118001A (en) Combination therapeutic compositions and methods of use
PL357713A1 (en) Caspase inhibitors and uses thereof
PL348343A1 (en) Method of obtaining prolonged-release microparticles and prolonged-release microparticles as such
HK1061669A1 (en) Processes and compositions for water treatment
TWI318207B (en) Carbamate caspase inhibitors and uses thereof
HUP0300855A3 (en) Peptidmomimetic protease inhibitors, pharmaceutical compositions and their use
GB0025782D0 (en) Use of inhibitors
AU3408801A (en) Tnf-alpha inhibitors
IL146000A0 (en) Ace-2 inhibiting compounds and methods of use thereof
ZA200208228B (en) Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis
AU6723401A (en) Antimicrobial peptides and methods of use thereof
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
IL153687A0 (en) Composition and method for enhancing elasticity of tissue
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
PL361836A1 (en) Prevention of hoof infections in stockbreeding
AU2001234962A1 (en) Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
EP1263935A4 (en) Scytonemin and methods of using thereof
IL152931A0 (en) BENZOPHENONES AS INHIBITORS OF IL-1beta AND TNF-alpha
GB0114231D0 (en) Treatment of multiple sclerosis
EP1414427A4 (en) Kavalactone compositions and methods of use
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
EP1303281A4 (en) Methods of treatment
EP1392460A4 (en) Hydrogenfluorides of aminosilanols and their use